Supplementary Figure S17 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
<p>(A) Structure of CAIX targeted SMDC AAZ-GlyPro-MMAE (6). (B) Ex vivo MMAE-release biodistribution performed 24 hours after systemic administration of compound 6 in SK-RC-52.hFAP and SK-RC-52-wt tumor-bearing Balb/c nude mice (n = 2 animals/group).</p>
Authors
- Sara Puglioli (ORCID: https://orcid.org/0000-0002-4795-7331)
- Lucrezia Principi (ORCID: https://orcid.org/0000-0002-0391-7995)
- Ettore Gilardoni (ORCID: https://orcid.org/0000-0002-2010-2667)
- Gabriele Bassi (ORCID: https://orcid.org/0000-0002-9439-8624)
- Dario Neri (ORCID: https://orcid.org/0000-0001-5234-7370)
- Samuele Cazzamalli (ORCID: https://orcid.org/0000-0003-0510-5664)
- Tony Georgiev (ORCID: https://orcid.org/0000-0001-8888-7096)
- Andrea Galbiati (ORCID: https://orcid.org/0000-0003-0725-0726)
- Christian Pellegrino (ORCID: https://orcid.org/0000-0001-7898-9988)
Publication Details
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1158/1535-7163.30255236
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00